Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

[1]  D. Steensma,et al.  On the TRAIL of a new therapy for leukemia , 2005, Leukemia.

[2]  A. Dispenzieri,et al.  Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  M. Tallman,et al.  New developments in antibody therapy for acute myeloid leukemia. , 2003, Seminars in oncology.

[4]  S. Rodenhuis,et al.  Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer , 2003, Bone Marrow Transplantation.

[5]  Santhosh K. P. Kumar,et al.  Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia , 2002, Leukemia.

[6]  P. Thall,et al.  Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission , 2002, British journal of haematology.

[7]  S. Ansell,et al.  Early lymphocyte recovery post‐autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease , 2002, British journal of haematology.

[8]  M. Lowdell,et al.  Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells , 2002, British journal of haematology.

[9]  S. Ansell,et al.  Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. , 2001, Blood.

[10]  J. Leonard,et al.  Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity. , 1999, Blood.

[11]  S. Fujii,et al.  Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients. , 1999, Cancer research.

[12]  Margaret Gross-King.  For Acute Myelogenous Leukemia and Myelodysplastic Syndrome: This list of clinical research protocols relating to acute myelogenous leukemia and myelodysplastic syndrome is compiled for your convenience. , 1997 .

[13]  A. Shad,et al.  Lymphocyte depletion during treatment with intensive chemotherapy for cancer. , 1994, Blood.

[14]  E. Lotzová,et al.  Role of natural killer cells in cancer. , 1993, Natural immunity.

[15]  E. Lotzová.  Definition and functions of natural killer cells. , 1993, Natural immunity.

[16]  E. Lotzová,et al.  Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth. , 1993, Natural immunity.

[17]  E. Lotzová,et al.  Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors. , 1993, Journal of immunology.

[18]  FOR PATIENTS WITH METASTATIC BREAST CANCER , 1978 .

[19]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .